Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.130
-0.060 (-1.88%)
At close: Aug 21, 2026, 4:00 PM EDT
3.180
+0.050 (1.60%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Cabaletta Bio Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Cabaletta Bio stock has a consensus rating of "Buy" and an average price target of $13.25. The average 1-year stock price forecast is 323.32% higher than the current stock price, while the lowest is $3.00 (-4.15%) and the highest is $30 (+858.47%).
Price Target: $13.25 (+323.32%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cabaletta Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $13 | Buy | Reiterates | $13 | +315.34% | Aug 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +858.47% | Aug 14, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $16 | Buy | Reiterates | $16 | +411.18% | Aug 14, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Reiterates $4 → $3 | Hold | Reiterates | $4 → $3 | -4.15% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.36
from -2.10
EPS Next Year
-1.48
from -1.36
EPS and Forward PE are based on non-GAAP adjusted numbers.